权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Hypothalamic glucokinase in obesity and diabetes

下丘脑葡萄糖激酶在肥胖和糖尿病中的作用

基本信息

批准号：
7837536
负责人：
CHARLES V MOBBS
金额：
$ 25.43万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-07-01 至 2011-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7837536
关键词：
Ablation Address Birth Body Weight Brain Cell Count Cells Code Complement Data Development Diabetes Mellitus Diet Ear Eating Ectopic Expression Exhibits Experimental Designs Fatty acid glycerol esters Gene Expression Genes Genetic Recombination Glial Fibrillary Acidic Protein Glucokinase Glucose Hand Homeostasis Hormones Hypothalamic structure Impairment In Vitro Individual Insulin Insulin Receptor Internal Ribosome Entry Site Knock-in Mouse Knock-out Knockout Mice LacZ Genes Leptin Liver Mediating Messenger RNA Metabolic Metabolic Control Metabolism Molecular Monitor Mus Neuroglia Neurons Neurosecretory Systems Obesity POMC gene Peripheral Pharmaceutical Preparations Phenotype Plasma Play Prevalence Property Proteins Public Health Publishing Regulation Reporting Role Sampling Series Site Specificity Structure of beta Cell of islet Temperature Terminator Codon Testing Tissues Toxic effect Transgenes Transgenic Mice Transgenic Organisms Translating Translations Weight maintenance regimen beta Actin beta-Galactosidase blood glucose regulation cell type energy balance glucose metabolism impaired glucose tolerance in vivo insulin tolerance neonatal diabetes mellitus nestin protein overexpression prevent promoter recombinase response restoration

项目摘要

Hypothalamic neurons can sense and respond to changes in glucose concentration, but the functional significance of this glucose-sensing property remains to be determined. As in pancreatic beta cells, glucokinase (GK) constitutes a key component of the hypothalamic glucose-sensing mechanism. Homozygous whole-body ablation of the GK gene produces lethal neonatal diabetes, and heterozygous whole-body ablation of the GK gene causes impaired glucose homeostasis and obese phenotypes, including reduced POMC and increased AgRP gene expression in hypothalamic neurons. Interestingly, homozygous whole-body ablation of the insulin receptor also produces lethal neonatal diabetes, and neuron-specific expression of the insulin receptor partially rescues this phenotype. We have now demonstrated that heterozygous and homozygous ablation of the GK gene specifically in neurons recapitulates the respective whole-body GK knockout phenotypes. On the other hand, other studies have suggested that GK in hypothalamic tanycytes (a type of glial cell) also plays a role in metabolic homeostasis. We therefore propose that different aspects of metabolic homeostasis are dependent on GK expression in POMC neurons, AgRP neurons, or tanycytes. To address this hypothesis, in Specific Aim 1 we propose to ablate GK specifically from POMC neurons by crossing transgenic mice expressing cre-recombinase under control of the POMC promoter (POMC-cre) with mice in which the GK gene is flanked by lox sites. Complementing these studies, we propose to restore GK specifically in POMC neurons in (homozygous or heterozygous) whole-body GK knockout mice, using the "knock-in" strategy by which Okamoto et al. rescued lethal neonatal diabetes by restoring insulin receptors specifically to neurons in whole-body insulin receptor knockout mice. Mice will be maintained on a low-fat or a high-fat diet. Metabolic phenotypes, including leptin sensitivity, glucose and insulin tolerance tests, food intake, body weight, adiposity, metabolic rate, and temperature will be assessed. Mice will be sacrificed, and gene expression will be determined in hypothalamus and other tissues. We propose similar studies in Specific Aims 2 and 3, using AgRP, or GFAP cre-recombinase (expressed in tanycytes) to ablate or restore GK specifically in in AgRP neurons, or to ablate GK in tanyctes. We anticipate that ablation of GK in specific hypothalamic cell types will partially recapitulate specific metabolic impairments produced by whole-body ablation of GK, and that restoration of GK to POMC or AgRP neurons will reverse specific metabolic impairments caused by whole- body GK deficiency

下丘脑神经元可以感受葡萄糖浓度的变化并作出反应，但功能性神经元的功能性变化不明显。这种葡萄糖感测特性的重要性仍有待确定。在胰腺β细胞中，葡萄糖激酶（GK）构成下丘脑葡萄糖敏感机制的关键组分。纯合 GK基因的全身消融产生致命的新生儿糖尿病，杂合子全身消融 GK基因的突变导致葡萄糖稳态受损和肥胖表型，包括POMC减少和下丘脑神经元AgRP基因表达增加。有趣的是，纯合子全身消融胰岛素受体也会产生致命的新生儿糖尿病，受体部分挽救了这种表型。我们现在已经证明了杂合子和纯合子特异性地在神经元中消除GK基因重现了相应的全身GK敲除表型另一方面，其他研究表明，下丘脑伸长细胞（一种类型的神经胶质细胞）也在代谢稳态中起作用。因此，我们建议，代谢的不同方面，稳态依赖于POMC神经元、AgRP神经元或伸长细胞中GK的表达。解决根据这一假设，在具体目标1中，我们建议通过交叉从POMC神经元中特异性消融GK 在POMC启动子控制下表达cre-重组酶的转基因小鼠（POMC-cre）， GK基因的侧翼是lox位点。为了补充这些研究，我们建议恢复GK 特别是在（纯合或杂合）全身GK敲除小鼠的POMC神经元中，使用 Okamoto等人通过恢复胰岛素受体挽救致命的新生儿糖尿病的“敲入”策略特别是对全身胰岛素受体敲除小鼠的神经元。小鼠将维持在低脂肪或高脂肪的环境中。高脂肪饮食。代谢表型，包括瘦素敏感性、葡萄糖和胰岛素耐受性测试、食物摄入量，将评估体重、肥胖、代谢率和体温。小鼠将被处死，基因将在下丘脑和其它组织中测定表达。我们建议在《特定目标》中进行类似的研究图2和图3中所示的方法，使用AgRP或GFAP cre重组酶（在伸长细胞中表达）特异性消融或恢复GK，在AgRP神经元中，或在tanyctes中消融GK。我们预期在特定的下丘脑细胞中去除GK 类型将部分重演GK全身消融产生的特定代谢损伤，将GK恢复为POMC或AgRP神经元将逆转由整体- 体GK缺乏症